Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Liver Diseases

  Free Subscription


01.09.2025

1 AJR Am J Roentgenol
1 Am J Pathol
2 Anticancer Res
1 Biochem Biophys Res Commun
3 BMC Gastroenterol
1 Cancer Res
2 Dig Dis Sci
1 Eur J Pediatr
1 Gastroenterology
1 Indian J Gastroenterol
2 J Hepatol
1 Oncogene
3 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LUDWIG DR
    Anatomic Considerations in Hepatocellular Carcinoma: How to Improve Reporting and Facilitate Treatment Selection.
    AJR Am J Roentgenol. 2025 Aug 27. doi: 10.2214/AJR.25.33753.
    PubMed        


    Am J Pathol

  2. OMAR DY, Willoughby MM, Mostafa N, Otakhor K, et al
    Lipid Droplet Dynamics in Alcoholic Steatohepatitis.
    Am J Pathol. 2025 Aug 26:S0002-9440(25)00299.
    PubMed         Abstract available


    Anticancer Res

  3. HO WH, Jhuang YC, Liang JA, Lin YC, et al
    Impact of Tumor Size on Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiotherapy.
    Anticancer Res. 2025;45:3961-3970.
    PubMed         Abstract available

  4. KOMORI H, Masuda T, Kurano R, Sugita H, et al
    A Rare Case of Fibrolamellar Hepatocellular Carcinoma in an Elderly Patient With Prior Hepatitis C Achieving Sustained Virologic Response.
    Anticancer Res. 2025;45:4047-4055.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  5. VARLAMOVA EG, Burmistrov DE, Gudkov SV, Rogachev VV, et al
    Comparative analysis of anticancer properties of So and selenium nanoparticles in a thioacetamide-induced HCC model.
    Biochem Biophys Res Commun. 2025;778:152364.
    PubMed         Abstract available


    BMC Gastroenterol

  6. WU W, Wu D, Chen F, Ding S, et al
    Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals.
    BMC Gastroenterol. 2025;25:620.
    PubMed         Abstract available

  7. ZHANG P, Zhuo J, Li H, Yang M, et al
    A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma.
    BMC Gastroenterol. 2025;25:622.
    PubMed         Abstract available

  8. ZHANG J, Chen Y, Ye P, Wu Q, et al
    Prognostic comparison between LNM and MaVI of hepatocellular carcinoma: a multicenter population-based propensity scores matching study.
    BMC Gastroenterol. 2025;25:618.
    PubMed         Abstract available


    Cancer Res

  9. RUAN YH, Ning WR, Huang AQ, Jiang D, et al
    Intracellular Interleukin-1alpha in Peritumoral Monocytes Induces IL8 Production and Inhibits Mitophagy to Promote Stemness and Metastasis of Hepatocellular Carcinoma.
    Cancer Res. 2025 Aug 26. doi: 10.1158/0008-5472.CAN-24-3355.
    PubMed         Abstract available


    Dig Dis Sci

  10. KUMAR A, Raj A, Chaman Lal K, Puja, et al
    Intratumoral Microbe Correlated with Expression of DNA Methylation Genes in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Aug 27. doi: 10.1007/s10620-025-09351.
    PubMed        

  11. LI K, Wang X, Wang Y, Zhu L, et al
    Exploring Cuproptosis-Related Prognostic Signature for Hepatocellular Carcinoma: Bioinformatics and In Vitro Analyses.
    Dig Dis Sci. 2025 Aug 28. doi: 10.1007/s10620-025-09354.
    PubMed         Abstract available


    Eur J Pediatr

  12. TOENNE M, Schaefer T
    Erythropoietic protoporphyria in childhood: clinical clues, missed diagnoses and emerging therapy.
    Eur J Pediatr. 2025;184:580.
    PubMed         Abstract available


    Gastroenterology

  13. LI L, Wang Y, Deng B
    A Patient with Liver Injury, Portal Hypertension, Anemia, and Peripheral Neuropathy.
    Gastroenterology. 2025 Aug 25:S0016-5085(25)05908.
    PubMed        


    Indian J Gastroenterol

  14. AHMAD J
    Child-Turcotte-Pugh score-based modified anti-tubercular treatment in patients with decompensated cirrhosis with tuberculosis: A two-year retrospective observational study from North India.
    Indian J Gastroenterol. 2025 Aug 29. doi: 10.1007/s12664-025-01860.
    PubMed         Abstract available


    J Hepatol

  15. CHAN SL, Lamarca A, Hsu C, Moreno V, et al
    New targets and new drugs for hepatobiliary cancers.
    J Hepatol. 2025 Aug 25:S0168-8278(25)02455-9. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available

  16. VERMA N, Kaur P, Jalan R
    Disease Staging and Clinical State in Cirrhosis: Is severity, acuity and pathophysiology the missing link?
    J Hepatol. 2025 Aug 25:S0168-8278(25)02456-0. doi: 10.1016/j.jhep.2025.
    PubMed        


    Oncogene

  17. HAN H, Gong C, Zhang Y, Liu C, et al
    RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma.
    Oncogene. 2025 Aug 29. doi: 10.1038/s41388-025-03550.
    PubMed         Abstract available


    PLoS One

  18. CHEN N, Zang B, Chen Y
    Predicting one-year post-surgical recurrence in colorectal liver metastasis using CT radiomics and machine learning.
    PLoS One. 2025;20:e0330828.
    PubMed         Abstract available

  19. EL ATIFI W, El Rhazouani O, Khan FM, Sekkat H, et al
    Optimizing ensemble machine learning models for accurate liver disease prediction in healthcare.
    PLoS One. 2025;20:e0330899.
    PubMed         Abstract available

  20. SUCULARLI C
    Machine learning-based identification of diagnostic and prognostic mitotic cell cycle genes in hepatocellular carcinoma.
    PLoS One. 2025;20:e0331118.
    PubMed         Abstract available


    Radiology

  21. XIA H, Min Y, Wang Y, Gao S, et al
    Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
    Radiology. 2025;316:e243780.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.